RaeSedo generates and optimizes new and improved structural peptidomimetics for the treatment of asthma.
RaeSedo has raised $3.4M in total funding. The most recent round was Grant. The last funding was announced in November 2022.
RaeSedo's investors include NSF Small Business Innovation Research / Small Business Technology Transfer (SBIR/STTR).
RaeSedo is headquartered in Arizona City, United States.
RaeSedo generates and optimizes new and improved structural peptidomimetics for the treatment of asthma.
RaeSedo is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"RaeSedo — Funding & Investors." VCBacked, November 16, 2022, https://www.vcbacked.co/company/raesedo. Accessed August 15, 2026.
VCBacked. (2022). RaeSedo — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/raesedo
{{cite web |title=RaeSedo — Funding & Investors |url=https://www.vcbacked.co/company/raesedo |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated